These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 10873516

  • 1. Endothelial monocyte activating polypeptide II induces endothelial cell apoptosis and may inhibit tumor angiogenesis.
    Berger AC, Alexander HR, Tang G, Wu PS, Hewitt SM, Turner E, Kruger E, Figg WD, Grove A, Kohn E, Stern D, Libutti SK.
    Microvasc Res; 2000 Jul; 60(1):70-80. PubMed ID: 10873516
    [Abstract] [Full Text] [Related]

  • 2. Sensitization of tumor necrosis factor alpha-resistant human melanoma by tumor-specific in vivo transfer of the gene encoding endothelial monocyte-activating polypeptide II using recombinant vaccinia virus.
    Gnant MF, Berger AC, Huang J, Puhlmann M, Wu PC, Merino MJ, Bartlett DL, Alexander HR, Libutti SK.
    Cancer Res; 1999 Sep 15; 59(18):4668-74. PubMed ID: 10493523
    [Abstract] [Full Text] [Related]

  • 3. Tumour necrosis factor receptor I (p55) is upregulated on endothelial cells by exposure to the tumour-derived cytokine endothelial monocyte- activating polypeptide II (EMAP-II).
    Berger AC, Alexander HR, Wu PC, Tang G, Gnant MF, Mixon A, Turner ES, Libutti SK.
    Cytokine; 2000 Jul 15; 12(7):992-1000. PubMed ID: 10880244
    [Abstract] [Full Text] [Related]

  • 4. Synergistic damage of tumor vessels with ultra low-dose endothelial-monocyte activating polypeptide-II and neovasculature-targeted tumor necrosis factor-alpha.
    Crippa L, Gasparri A, Sacchi A, Ferrero E, Curnis F, Corti A.
    Cancer Res; 2008 Feb 15; 68(4):1154-61. PubMed ID: 18281491
    [Abstract] [Full Text] [Related]

  • 5. In vivo therapy of local tumor progression by targeting vascular endothelium with EMAP-II.
    Schwarz RE, Schwarz MA.
    J Surg Res; 2004 Jul 15; 120(1):64-72. PubMed ID: 15172191
    [Abstract] [Full Text] [Related]

  • 6. In vivo sensitivity of human melanoma to tumor necrosis factor (TNF)-alpha is determined by tumor production of the novel cytokine endothelial-monocyte activating polypeptide II (EMAPII).
    Wu PC, Alexander HR, Huang J, Hwu P, Gnant M, Berger AC, Turner E, Wilson O, Libutti SK.
    Cancer Res; 1999 Jan 01; 59(1):205-12. PubMed ID: 9892208
    [Abstract] [Full Text] [Related]

  • 7. Endothelial monocyte activating polypeptide II (EMAP II) enhances the effect of TNF on tumor-associated vasculature.
    Kayton ML, Libutti SK.
    Curr Opin Investig Drugs; 2001 Jan 01; 2(1):136-8. PubMed ID: 11527006
    [Abstract] [Full Text] [Related]

  • 8. Endothelial monocyte-activating polypeptide-II (EMAP-II): a novel inducer of lymphocyte apoptosis.
    Murray JC, Heng YM, Symonds P, Rice K, Ward W, Huggins M, Todd I, Robins RA.
    J Leukoc Biol; 2004 May 01; 75(5):772-6. PubMed ID: 14982944
    [Abstract] [Full Text] [Related]

  • 9. Endothelial monocyte activating polypeptide-II induced gene expression changes in endothelial cells.
    Tandle AT, Mazzanti C, Alexander HR, Roberts DD, Libutti SK.
    Cytokine; 2005 Jun 21; 30(6):347-58. PubMed ID: 15935955
    [Abstract] [Full Text] [Related]

  • 10. Apoptosis induced by a corneal-endothelium-derived cytokine.
    Liu SH, Gottsch JD.
    Invest Ophthalmol Vis Sci; 1999 Dec 21; 40(13):3152-9. PubMed ID: 10586937
    [Abstract] [Full Text] [Related]

  • 11. Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas.
    Herr I, Ucur E, Herzer K, Okouoyo S, Ridder R, Krammer PH, von Knebel Doeberitz M, Debatin KM.
    Cancer Res; 2003 Jun 15; 63(12):3112-20. PubMed ID: 12810637
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. EMAP-II facilitates TNF-R1 apoptotic signalling in endothelial cells and induces TRADD mobilization.
    van Horssen R, Rens JA, Schipper D, Eggermont AM, ten Hagen TL.
    Apoptosis; 2006 Dec 15; 11(12):2137-45. PubMed ID: 17051333
    [Abstract] [Full Text] [Related]

  • 14. Heparan sulfate regulates the antiangiogenic activity of endothelial monocyte-activating polypeptide-II at acidic pH.
    Chang SY, Ko HJ, Heo TH, Kang CY.
    Mol Pharmacol; 2005 May 15; 67(5):1534-43. PubMed ID: 15710745
    [Abstract] [Full Text] [Related]

  • 15. Up-Regulation of Bcl-2 in microvascular endothelial cells enhances intratumoral angiogenesis and accelerates tumor growth.
    Nör JE, Christensen J, Liu J, Peters M, Mooney DJ, Strieter RM, Polverini PJ.
    Cancer Res; 2001 Mar 01; 61(5):2183-8. PubMed ID: 11280784
    [Abstract] [Full Text] [Related]

  • 16. The C-terminal domain of canstatin suppresses in vivo tumor growth associated with proliferation of endothelial cells.
    He GA, Luo JX, Zhang TY, Hu ZS, Wang FY.
    Biochem Biophys Res Commun; 2004 May 28; 318(2):354-60. PubMed ID: 15120609
    [Abstract] [Full Text] [Related]

  • 17. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
    Zhang GM, Zhang YM, Fu SB, Liu XH, Fu X, Yu Y, Zhang ZY.
    Chin Med J (Engl); 2008 Nov 20; 121(22):2324-30. PubMed ID: 19080341
    [Abstract] [Full Text] [Related]

  • 18. Induction of a TRAIL-mediated suicide program by interferon alpha in primary effusion lymphoma.
    Toomey NL, Deyev VV, Wood C, Boise LH, Scott D, Liu LH, Cabral L, Podack ER, Barber GN, Harrington WJ.
    Oncogene; 2001 Oct 25; 20(48):7029-40. PubMed ID: 11704827
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases.
    Bruns CJ, Liu W, Davis DW, Shaheen RM, McConkey DJ, Wilson MR, Bucana CD, Hicklin DJ, Ellis LM.
    Cancer; 2000 Aug 01; 89(3):488-99. PubMed ID: 10931447
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.